Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.78
-0.09 (-1.53%)
Aug 14, 2025, 2:28 PM - Market open

Myriad Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
5381,2481,6971,1762,2041,487
Upgrade
Market Cap Growth
-77.89%-26.46%44.34%-46.65%48.19%75.92%
Upgrade
Enterprise Value
6201,2911,8121,0541,8841,588
Upgrade
Last Close Price
5.8713.7119.1414.5127.6019.77
Upgrade
Forward PE
154.00141.34----
Upgrade
PS Ratio
0.641.492.251.733.192.67
Upgrade
PB Ratio
1.411.782.171.332.281.69
Upgrade
P/TBV Ratio
3.248.3811.985.546.94-
Upgrade
P/FCF Ratio
----3673.31-
Upgrade
P/OCF Ratio
----118.49-
Upgrade
EV/Sales Ratio
0.741.542.411.552.732.85
Upgrade
EV/FCF Ratio
----3139.65-
Upgrade
Debt / Equity Ratio
0.400.200.190.160.100.33
Upgrade
Debt / EBITDA Ratio
206.13-----
Upgrade
Debt / FCF Ratio
----153.83-
Upgrade
Asset Turnover
0.950.770.640.540.50-
Upgrade
Inventory Turnover
8.9910.1911.2211.419.32-
Upgrade
Quick Ratio
1.061.361.641.582.111.65
Upgrade
Current Ratio
1.421.822.012.002.372.67
Upgrade
Return on Equity (ROE)
-70.03%-17.15%-31.55%-12.08%-2.94%-
Upgrade
Return on Assets (ROA)
-5.44%-5.06%-7.40%-6.14%-5.78%-
Upgrade
Return on Capital (ROIC)
-6.72%-6.19%-8.83%-7.40%-7.10%-
Upgrade
Earnings Yield
-73.23%-10.20%-15.52%-9.53%-1.23%-15.04%
Upgrade
FCF Yield
-7.00%-2.22%-10.26%-12.89%0.03%-2.70%
Upgrade
Buyback Yield / Dilution
-4.87%-9.42%-2.73%-3.33%-4.31%-0.64%
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q